Publication | Closed Access

FGF21 exerts comparable pharmacological efficacy with Adalimumab in ameliorating collagen-induced rheumatoid arthritis by regulating systematic inflammatory response

InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune DiseaseRheumatic DiseasesImmunologySystematic Inflammatory ResponseOsteoarthritisPathologyFibroblast Growth FactorInflammatory Rheumatic DiseaseCollagen-induced Rheumatoid ArthritisComparable Pharmacological EfficacyMedicineInflammatory DiseaseTumor MicroenvironmentRheumatoid Arthritis